RECRUITINGPhase 3INTERVENTIONAL
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial
About This Trial
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Who May Be Eligible (Plain English)
Who May Qualify:
- Children with traumatic brain injury: Moderate and Severe.
Who Should NOT Join This Trial:
- Underlying CNS disorders,
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Children with traumatic brain injury: Moderate and Severe.
Exclusion Criteria:
* Underlying CNS disorders,
Treatments Being Tested
DRUG
Nucleo CMP Forte
Nucleo CMP Forte twice daily for 6 weeks
Locations (1)
Sherief Abd-Elsalam
Tanta, Egypt